EA201992275A3 - Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения - Google Patents
Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их полученияInfo
- Publication number
- EA201992275A3 EA201992275A3 EA201992275A EA201992275A EA201992275A3 EA 201992275 A3 EA201992275 A3 EA 201992275A3 EA 201992275 A EA201992275 A EA 201992275A EA 201992275 A EA201992275 A EA 201992275A EA 201992275 A3 EA201992275 A3 EA 201992275A3
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- derivatives
- well
- bisamides
- producing
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Addiction (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- AIDS & HIV (AREA)
Abstract
Настоящее изобретение относится к новым биологически активным соединениям, производным бисамидов дикарбоновых кислот общей формулы Iили их фармацевтически приемлемым солям, обладающим способностью к комплексообразованию или хелатированию ионов металлов, а также их применению в качестве средства для профилактики и/или лечения сердечно-сосудистых, вирусных, онкологических, нейродегенеративных, воспалительных заболеваний, диабета, геронтологических заболеваний, а также заболеваний, вызываемых токсинами микроорганизмов, а также алкоголизма, алкогольного цирроза печени, анемии, поздней порфирии, отравлений солями переходных металлов. Настоящее изобретение также относится к новым способам получения производных бисамидов дикарбоновых кислот общей формулы I.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013116822A RU2665688C2 (ru) | 2013-04-12 | 2013-04-12 | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения |
Publications (3)
Publication Number | Publication Date |
---|---|
EA201992275A2 EA201992275A2 (ru) | 2020-01-16 |
EA201992275A3 true EA201992275A3 (ru) | 2020-04-30 |
EA039440B1 EA039440B1 (ru) | 2022-01-27 |
Family
ID=51689820
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202190774A EA202190774A3 (ru) | 2013-04-12 | 2014-04-10 | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения |
EA202092453A EA202092453A3 (ru) | 2013-04-12 | 2014-04-10 | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения |
EA202190775A EA202190775A1 (ru) | 2013-04-12 | 2014-04-10 | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения |
EA201992275A EA039440B1 (ru) | 2013-04-12 | 2014-04-10 | Производное бисамидов дикарбоновых кислот |
EA202092452A EA202092452A3 (ru) | 2013-04-12 | 2014-04-10 | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция, на их основе, способы их получения |
EA201501014A EA036961B1 (ru) | 2013-04-12 | 2014-04-10 | Производное бисамидов дикарбоновых кислот |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202190774A EA202190774A3 (ru) | 2013-04-12 | 2014-04-10 | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения |
EA202092453A EA202092453A3 (ru) | 2013-04-12 | 2014-04-10 | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения |
EA202190775A EA202190775A1 (ru) | 2013-04-12 | 2014-04-10 | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202092452A EA202092452A3 (ru) | 2013-04-12 | 2014-04-10 | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция, на их основе, способы их получения |
EA201501014A EA036961B1 (ru) | 2013-04-12 | 2014-04-10 | Производное бисамидов дикарбоновых кислот |
Country Status (26)
Country | Link |
---|---|
US (3) | US20160031858A1 (ru) |
EP (1) | EP2985284B1 (ru) |
JP (1) | JP6760837B2 (ru) |
KR (1) | KR102218134B1 (ru) |
CN (6) | CN109096200B (ru) |
AU (1) | AU2014251443C1 (ru) |
BR (1) | BR112015025675B1 (ru) |
CA (1) | CA2909411C (ru) |
CY (1) | CY1125062T1 (ru) |
DK (1) | DK2985284T3 (ru) |
EA (6) | EA202190774A3 (ru) |
ES (1) | ES2904568T3 (ru) |
HK (1) | HK1221223A1 (ru) |
HR (1) | HRP20220103T1 (ru) |
HU (1) | HUE057209T2 (ru) |
IL (1) | IL242029B (ru) |
LT (1) | LT2985284T (ru) |
MX (2) | MX2015014213A (ru) |
PL (1) | PL2985284T3 (ru) |
PT (1) | PT2985284T (ru) |
RS (1) | RS62889B1 (ru) |
RU (1) | RU2665688C2 (ru) |
SG (2) | SG10202008505VA (ru) |
SI (1) | SI2985284T1 (ru) |
UA (1) | UA119748C2 (ru) |
WO (1) | WO2014168523A1 (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9815814B2 (en) * | 2013-04-12 | 2017-11-14 | Obschestvo S Ogranichennoi Otvetstvennostiyu “Pharmenterprises” | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
RU2665688C2 (ru) * | 2013-04-12 | 2018-09-04 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения |
RU2647438C2 (ru) * | 2015-05-27 | 2018-03-15 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Бисамидное производное дикарбоновой кислоты в качестве средства, стимулирующего регенерацию тканей и восстановление сниженных функций тканей |
RU2665633C1 (ru) * | 2017-05-26 | 2018-09-03 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Новый ингибитор глутаминилциклаз и его применение |
WO2018217139A1 (ru) * | 2017-05-26 | 2018-11-29 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Новые ингибиторы глутаминилциклаз и их применение для лечения различных заболеваний |
RU2662559C1 (ru) * | 2017-10-27 | 2018-07-26 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Новый ингибитор глутаминилциклаз и его применение для лечения заболеваний легких и дыхательных путей |
WO2018237163A1 (en) * | 2017-06-23 | 2018-12-27 | Roman Manetsch | 5-AMINOLEVULINATE SYNTHASE INHIBITORS AND METHODS OF USE |
RU2685277C1 (ru) * | 2018-05-24 | 2019-04-17 | Общество с ограниченной ответственностью "Фарминтерпрайсез Аллерджи" | Применение бисамидного производного малоновой кислоты для лечения аллергических и других заболеваний человека и животных |
RU2679636C1 (ru) * | 2018-10-29 | 2019-02-12 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Новый способ получения n,n'-бис[2-(1н-имидазол-4-ил)этил]малонамида |
WO2021049980A1 (ru) * | 2019-09-12 | 2021-03-18 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Новые составы для лечения и профилактики вирусных заболеваний |
RU2746692C1 (ru) * | 2020-04-14 | 2021-04-19 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Новые составы 2-(имидазол-4-ил)-этанамида пентандиовой-1,5 кислоты для лечения и профилактики вирусных заболеваний |
RU2745265C2 (ru) * | 2019-09-12 | 2021-03-22 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Новые составы 2-(имидазол-4-ил)-этанамида пентандиовой-1,5 кислоты для лечения и профилактики вирусных заболеваний |
WO2023177328A1 (en) | 2022-03-17 | 2023-09-21 | Treamid Therapeutics Gmbh | Bisamide derivative of dicarboxylic acid for use in restoring the external respiratory function after coronavirus infection |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6169759A (ja) * | 1984-09-14 | 1986-04-10 | Agency Of Ind Science & Technol | タンパク質の架橋反応用修飾剤及びそれを用いる方法 |
JPS6344567A (ja) * | 1986-08-08 | 1988-02-25 | Shikoku Chem Corp | 新規なイミダゾール系ジアミド化合物、該化合物の合成方法および該化合物を有効成分とするポリエポキシ樹脂硬化剤 |
IL86131A0 (en) * | 1987-04-24 | 1988-11-15 | Boehringer Ingelheim Kg | Benzo-and thieno-3,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them |
AU2001283740A1 (en) * | 2000-08-17 | 2002-02-25 | University Of British Columbia | Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours |
RU2287524C1 (ru) * | 2005-03-31 | 2006-11-20 | ООО "Фарминтерпрайсез" | Аспартильные производные гистамина, способ их получения, фармацевтическая композиция и их применение в качестве модуляторов активности ферментов антиоксидантной защиты |
RU2335495C2 (ru) * | 2005-06-15 | 2008-10-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | N-ацильные производные аминокислот, их фармацевтически приемлевые соли, фармацевтическая композиция и применение в качестве гиполипидемических средств |
CN1919884A (zh) * | 2005-08-26 | 2007-02-28 | 建筑技术研究有限公司 | 基于氧化烯二醇烯基醚和不饱和二羧酸衍生物的共聚物 |
EP1957461B1 (en) * | 2005-11-14 | 2016-11-02 | Genentech, Inc. | Bisamide inhibitors of hedgehog signaling |
EP1884515A1 (en) * | 2006-07-31 | 2008-02-06 | Laboratorios del Dr. Esteve S.A. | Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
JP6079148B2 (ja) * | 2012-11-07 | 2017-02-15 | Jsr株式会社 | 液晶配向剤、液晶配向膜及び液晶表示素子 |
RU2665688C2 (ru) * | 2013-04-12 | 2018-09-04 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения |
JP6169759B1 (ja) * | 2016-07-11 | 2017-07-26 | 株式会社山寿セラミックス | 弾性表面波素子用基板及びその製造方法 |
-
2013
- 2013-04-12 RU RU2013116822A patent/RU2665688C2/ru active
-
2014
- 2014-04-10 EA EA202190774A patent/EA202190774A3/ru unknown
- 2014-04-10 SG SG10202008505VA patent/SG10202008505VA/en unknown
- 2014-04-10 CN CN201811167690.4A patent/CN109096200B/zh active Active
- 2014-04-10 CN CN201811168167.3A patent/CN109134378B/zh active Active
- 2014-04-10 EA EA202092453A patent/EA202092453A3/ru unknown
- 2014-04-10 CA CA2909411A patent/CA2909411C/en active Active
- 2014-04-10 EP EP14782759.6A patent/EP2985284B1/en active Active
- 2014-04-10 HR HRP20220103TT patent/HRP20220103T1/hr unknown
- 2014-04-10 MX MX2015014213A patent/MX2015014213A/es unknown
- 2014-04-10 CN CN201811167661.8A patent/CN109096198B/zh active Active
- 2014-04-10 CN CN201811167688.7A patent/CN109096199B/zh active Active
- 2014-04-10 CN CN201480027307.9A patent/CN105358548A/zh active Pending
- 2014-04-10 CN CN201811167650.XA patent/CN109336819B/zh active Active
- 2014-04-10 SI SI201431938T patent/SI2985284T1/sl unknown
- 2014-04-10 ES ES14782759T patent/ES2904568T3/es active Active
- 2014-04-10 AU AU2014251443A patent/AU2014251443C1/en active Active
- 2014-04-10 UA UAA201510873A patent/UA119748C2/uk unknown
- 2014-04-10 BR BR112015025675-9A patent/BR112015025675B1/pt active IP Right Grant
- 2014-04-10 RS RS20220090A patent/RS62889B1/sr unknown
- 2014-04-10 PL PL14782759T patent/PL2985284T3/pl unknown
- 2014-04-10 DK DK14782759.6T patent/DK2985284T3/da active
- 2014-04-10 SG SG11201508342RA patent/SG11201508342RA/en unknown
- 2014-04-10 EA EA202190775A patent/EA202190775A1/ru unknown
- 2014-04-10 HU HUE14782759A patent/HUE057209T2/hu unknown
- 2014-04-10 EA EA201992275A patent/EA039440B1/ru unknown
- 2014-04-10 KR KR1020157032328A patent/KR102218134B1/ko active IP Right Grant
- 2014-04-10 PT PT147827596T patent/PT2985284T/pt unknown
- 2014-04-10 WO PCT/RU2014/000265 patent/WO2014168523A1/ru active Application Filing
- 2014-04-10 LT LTEPPCT/RU2014/000265T patent/LT2985284T/lt unknown
- 2014-04-10 EA EA202092452A patent/EA202092452A3/ru unknown
- 2014-04-10 EA EA201501014A patent/EA036961B1/ru unknown
- 2014-04-10 JP JP2016507513A patent/JP6760837B2/ja active Active
-
2015
- 2015-10-08 MX MX2020013371A patent/MX2020013371A/es unknown
- 2015-10-09 US US14/879,648 patent/US20160031858A1/en not_active Abandoned
- 2015-10-12 IL IL242029A patent/IL242029B/en active IP Right Grant
-
2016
- 2016-08-08 HK HK16109432.9A patent/HK1221223A1/zh unknown
-
2021
- 2021-11-18 US US17/530,143 patent/US20220324843A1/en active Pending
-
2022
- 2022-02-03 CY CY20221100101T patent/CY1125062T1/el unknown
- 2022-12-21 US US18/086,141 patent/US20230203016A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201992275A2 (ru) | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения | |
EA201490747A1 (ru) | 1-арилкарбонил-4-оксипиперидиновые соединения, полезные для лечения нейродегенеративных заболеваний | |
EA201591122A1 (ru) | Гетероциклическое соединение | |
EA201590913A1 (ru) | АЛКИЛАМИДЗАМЕЩЕННЫЕ ПИРИДИЛЬНЫЕ СОЕДИНЕНИЯ, ПРИМЕНИМЫЕ В КАЧЕСТВЕ МОДУЛЯТОРОВ ОТВЕТОВ, ОПОСРЕДУЕМЫХ IL-12, IL-23 И/ИЛИ IFNα | |
EA201892050A1 (ru) | Способ получения замещенных 5-фтор-1h-пиразолопиридинов | |
BR112014013108A2 (pt) | compostos tricíclicos fundidos como inibidores da quinase raf | |
EA201491857A1 (ru) | АЛЛОСТЕРИЧЕСКИЕ МОДУЛЯТОРЫ α7 НИКОТИНОВОГО ХОЛИНОРЕЦЕПТОРА, ИХ ПРОИЗВОДНЫЕ И ИХ ПРИМЕНЕНИЕ | |
EA201492287A1 (ru) | Дейтерированные производные руксолитиниба | |
EA201792597A2 (ru) | Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения | |
EA201691141A1 (ru) | Соединения против ccr6 | |
MX2018014164A (es) | Intermedios para la sintesis de derivados de acido biliar, en particular, de acido obeticolico. | |
EA201590475A1 (ru) | Тетрациклиновые соединения | |
EA201391371A1 (ru) | Фармацевтическая композиция ситаглиптина | |
MX2018000012A (es) | Composiciones y metodos para diagnosis y tratamiento de condiciones relacionadas a inflamacion. | |
GB201308503D0 (en) | Novel microbiocides | |
MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
EA201270610A1 (ru) | Хинуклидиновые соединения как альфа-7 лиганды ацетилхолинового рецептора | |
BR112013026131A2 (pt) | kit e método para colorir cabelo | |
WO2014102820A3 (en) | Rivaroxaban intermediate and preparation thereof | |
BR112014006401A2 (pt) | tetraidrato de sal de l-arginina de ácido s-(-)9-fluoro-6,7-di-hidro-8-(4-hidroxipiperidin-1-il)-5-metil-1-oxo-1h,-5h-benzo[i,j]quinolizina-2-carboxílico puro e um processo para sua produção | |
TH1701003364A (th) | กรด 3-(6-แอลคอกซี-5-คลอโรเบนโซ[d]ไอซอกซาโซล-3-อิล) โพรพาโนอิกที่มีประโยชน์ในฐานะสารยับยั้งไคนูเรนีนโมโนออกซีจีเนส | |
TH155609A (th) | อนุพันธ์ของบีทูลิน | |
EA201490678A1 (ru) | Хинуклидиновые соединения как альфа-7 лиганды ацетилхолинового рецептора | |
TH135149B (th) | สารรักษาโรคหรือป้องกันโรคสำหรับโรคทางเดินน้ำดี |